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Int J Geriatr Psychiatry. 2018;33:1163–1176.Objectives: To synthesise the existing published literature on general practitioners
(GP)'s knowledge, attitudes, and experiences of managing behavioural and psycholog-
ical symptoms of dementia (BPSD) with a view to informing future interventions.
Methods: We conducted a systematic review and synthesis of quantitative and
qualitative studies that explored GPs' experiences of managing BPSD (PROSPERO
protocol registration CRD42017054916). Seven electronic databases were searched
from inception to October 2017. Each stage of the review process involved at least
2 authors working independently. The meta‐ethnographic approach was used to
synthesise the findings of the included studies while preserving the context of the
primary data. The Confidence in the Evidence from Reviews of Qualitative research
(CERQual) was used to assess the confidence in our individual review findings.
Results: Of the 1638 articles identified, 76 full texts were reviewed and 11 were
included. Three main concepts specific to GPs' experiences of managing BPSD
emerged: unmet primary care resource needs, justification of antipsychotic prescrib-
ing, and the pivotal role of families. A “line of argument” was drawn, which described
how in the context of resource limitations a therapeutic void was created. This
resulted in GPs being over reliant on antipsychotics and family caregivers. These
factors appeared to culminate in a reactive response to BPSD whereby behaviours
and symptoms could escalate until a crisis point was reached.
Conclusion: This systematic review offers new insights into GPs' perspectives on
the management of BPSD and will help to inform the design and development of
interventions to support GPs managing BPSD.
KEYWORDS
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Key points
• This is first review to systematically review and
synthesise the existing literature on GPs' knowledge,
attitudes, and experiences of managing BPSD.
• A number of issues were identified including the
knowledge and resource needs of GPs, their reliance
on antipsychotic medications, and the influential role
of family.
• While offering new insights into GPs' perspectives on
the management of BPSD, this review highlights the
limited research conducted in this area to date.
• This review will help to inform the design and
development of interventions to support GPs
managing BPSD.
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General practitioners (GPs) play a pivotal role in the care of people with
dementia and their families.1-3 National strategies developed to address
the increased prevalence of dementia4 have emphasised the role of GPs
in successful implementation5-7 but dementia care in the community can
be challenging.8,9 In common with their hospital‐based colleagues,10
General practitioners find the management of the behavioural and
psychological symptoms of dementia (BPSD) particularly difficult.11-14
Behavioural and psychological symptoms of dementia encompass
behaviours such as aggression, wandering, sexual disinhibition, agita-
tion, and symptoms such as anxiety, depression, and delusions. Most
people with dementia will experience BPSD at some time during their
illness.15 Behavioural and psychological symptoms of dementia are
associated with increased rates of admission to nursing homes,16 lon-
ger in‐patient hospital stays,17 and are a major contributor to caregiver
stress and depression.18 The assessment of BPSD is complex,19 and
effective treatment options are limited. Non‐pharmacological inter-
ventions are recommended as the first line of treatment in most
cases.20 Personalised non‐pharmacological interventions such as
personalised music therapy21,22 and formal caregiver training to
enhance communication skills22 may have a role in the management
of BPSD; however, uptake of non‐pharmacological strategies is
low.23 Psychotropic medications such as antipsychotics, anxiolytics,
hypnotics, and antidepressants are frequently used to manage
BPSD.24,25 Antipsychotics are the most commonly prescribed psycho-
tropic in BPSD24; however, the benefits of antipsychotics in BPSD are
modest at best.26 Furthermore, in BPSD, any benefits are usually off-
set by the significant adverse effects of antipsychotics in dementia,
including increased risk of cerebrovascular events and increased mor-
tality.26-29 However, based on current available evidence, pharmaco-
logical alternatives to antipsychotics in BPSD are largely
ineffective.30-34 Although there may be a role for citalopram in manag-
ing milder agitation,35 it too can result in significant side‐effects
including QT prolongation and worsening of cognitive impairment.36
There is a need for interventions designed to support GPs in their
management of BPSD. An important first step in intervention design is
to establish a thorough understanding of the existing problem.37,38
The aim of this systematic review was to gain a deeper understanding
of GPs' knowledge, attitudes, and experiences of managing BPSD. It
will also inform the development of an intervention to assist GPs with
the management of BPSD.2 | METHODS
We performed a systematic review of studies that used qualitative or
quantitative methods to explore GPs' experiences of managing
BPSD.39 A mixed‐methods approach was used to ensure that all rele-
vant literature was included.40 To synthesise the qualitative and quan-
titative results, an integrated design was adopted.41 This involved
transforming quantitative data obtained from GPs' responses to
standardised questionnaires into qualitative form so that it could be
combined with data from qualitative studies and subjected to qualita-
tive analysis. Once the data were in qualitative form, the synthesis wasguided by the meta‐ethnographic approach as described by Noblit and
Hare.42 Meta‐ethnography goes beyond merely describing or
summarising the literature: the aim is to use the source material to
develop original interpretations by accounting for both the context
of the research and the reported findings.
The review was registered with the International Prospective
Register of Systematic Reviews (PROSPERO) (registration number
42017054916). Table 1 outlines the eligibility and exclusion criteria.
We included all studies that explored the knowledge, attitude, or
experiences of GPs in the management of BPSD in the community
and in nursing home settings. Studies that did not describe in detail
the knowledge and attitudes of practising GPs in relation to BPSD
were excluded. Studies that focused on GPs who sub‐specialised in
elderly care medicine and now work exclusively as specialist elderly
care physicians in nursing home settings43 were excluded from this
review. It was considered that as a result of their specialist training,
the knowledge and attitudes of these specialist elderly care physicians
towards BPSD would not be representative of GPs generally.
Seven electronic bibliographic databases were searched from
inception to present: MEDLINE (Ovid), Embase (Elsevier), CINAHL,
PsychINFO, Academic Search Complete, SocIndex, and Social Science
Full Text. The initial search was conducted in June 2017 and repeated
on 25 October 2017. The search strategy was developed by using
database‐specific search terms with input from a health services librar-
ian. The MEDLINE search strategy is displayed in Table 2. Other
search methods used included hand‐searching key journals and con-
ference proceedings, citation searching of highly cited key papers,
and scanning reference lists of key papers.
For the first stage of abstract screening, duplicates and clearly
irrelevant studies (for example pre‐clinical studies) were removed by
one reviewer (A.J.). In the next stage, 2 independent reviewers from
the screening team (A.J., T.F., A.C., and C.B.) independently screened
each study abstract. All eligible studies were then assessed by 2 inde-
pendent reviewers. Any conflicts regarding the eligibility of a study
were resolved through discussion between the paired teams. Where
necessary, a third reviewer adjudicated and made the final decision
TABLE 1 Eligibility criteria for studies in the systematic review
Inclusion Criteria Exclusion Criteria
‐ Studies that explore the knowledge, attitude or experiences of GPs in the
management of BPSD in nursing homes and/or in the community
‐ Qualitative or quantitative study design
‐ Studies must include GPs
‐ Studies that do not describe in detail the knowledge and attitudes of
general practitioners in relation to BPSD
‐ Non‐English language studies
‐ Studies reporting the perspective of non‐GP health care professionals
where the views of GPs are not represented or analysed separately
‐ Studies reporting on GPs' perspectives on managing another aspect of
dementia without any reference to the management of BPSD
‐ Opinion pieces and non‐peer reviewed articles
Abbreviations: BPSD, behavioural and psychological symptoms of dementia; GPs, general practitioners.
TABLE 2 The MEDLINE, Ovid search strategy
Primary Care Physicians Dementia BPSD
MeSH terms
/subheadings
Exp Primary Health Care/
Exp General Practice
Family Practice/
Exp General Practitioners/
Exp Physicians, Family/
Exp Physicians, Primary Care/
Exp Dementia/
Exp Alzheimer Disease/
Exp Antipsychotic Agents/
Exp Anxiety/
Exp Aggression/
Exp Wandering behavior/
Exp Sleep Disorders/
Exp Apathy/
Exp Irritable Mood/
Exp Psychotic Disorders/
Exp Depression/
Text words family medicine. ti, ab dementia. ti,ab. alzheimer*.ti, ab.
(cognitive adj (impairment or decline)).ti, ab
Behavio?ral and psychological symptom*ti, ab
BPSD.ti, ab
Challenging behavio? r*ti, ab
Responsive behavio? r*.ti, ab
Neuropsychiatric symptom*.ti, ab
Non‐cognitive symptom*.ti, ab
Noncognitive symptom*.ti, ab
Psychological symptom*.ti, ab
Psychiatric symptom*.ti, ab
Difficult behav*.ti, ab
Disruptive behav*.ti, ab
Behavio?ral symptom*.ti, ab
(agitated or agitation).ti, ab
(depressed or depression).ti, ab
(anxiety or anxious).ti, ab (aggressive* behav*).ti, ab
JENNINGS ET AL. 1165regarding inclusion. All studies that were excluded after full‐text
screening are listed, with their reason for exclusion, in File S1.
Data concerning participant characteristics, aims, setting,
and methods were extracted independently by 2 reviewers (A.J. and
T.F.). Members of the review team independently read and re‐read
all the eligible studies in chronological order focusing initially on the
content and context. The lead author (A.J.) open coded all the included
studies focusing specifically on the first‐order interpretations (views of
participants) and second‐order interpretations (views of the authors).
In the qualitative studies, the first‐order interpretations focused on
the attitudes and experiences of GPs as presented in the result
sections of the studies. In the quantitative studies, the first‐order
interpretations were identified from participants' responses to ques-
tionnaire items and a text file was created describing these responses.
Second‐order interpretations were derived from the discussions and
conclusions. At this point, the data collected from quantitative and
qualitative studies were no longer distinguishable, enabling the
synthesis of all the data in qualitative form. The software package
NVivo 11 was used to facilitate data analysis and synthesis.
To ensure credibility and dependability of coding, a second
reviewer (K.W.) also coded 3 studies.44-46 Conceptual groupings were
created for each study and illustrated with conceptual mind maps. The
2 reviewers involved (A.J. and K.W.) met regularly to discussdifferences in interpretation of the studies. All 4 members of the anal-
ysis team (A.J., K.W., C.B., and T.F.) met to discuss the key concepts
emerging from the analysis of the included studies. To determine
how the studies related to each other, a table was iteratively devel-
oped that displayed the identified concepts and themes across all
studies (File S2). To examine the contribution of each study to a key
concept, the review team compared the themes and concepts from
each individual study in chronological order. Attention was paid to
deviant cases and to the influence of context on the study findings.
The third‐order interpretations were iteratively developed by the anal-
ysis team. Finally, the analysis team collectively linked the third‐order
interpretations into a “line of argument,”42 which represents the over-
arching perspective of GPs towards BPSD.
All included papers were independently assessed by 2 reviewers
(A.J. and J.B.) for methodological validity. A. J. was a co‐author on one
of the included studies12; therefore, the quality assessment of that study
was carried out by C.B. and J.B. The Joanna Briggs Institute Critical
Appraisal Checklist forQualitative Researchwas used to assess thequal-
ity of the included qualitative studies.47 Since there is no agreed quality
assessment tool for assessing the quality of descriptive cross‐sectional
studies, a new original tool was developed by 2 of the reviewers (A.J.
and J.B.). This tool was based on other original tools developed for a
similar purpose48,49 and also considered recommendations on how
1166 JENNINGS ET AL.survey questionnaires should be designed.50 This tool is available in File
S3. Judgements on the quality of the study were not used to exclude
studies that otherwise meet the inclusion criteria.
We report our results to conform with the Enhancing Transpar-
ency in Reporting the Synthesis of Qualitative Research (ENTREQ)
statement51 (File S4). We express our search strategy results by using
the Preferred Reporting Items for Systematic Reviews and Meta‐
Analyses (PRISMA) flow diagram52 (Figure 1). Two independent
reviewers (A.J. and K.W.) applied the Confidence in the Evidence from
Reviews of Qualitative Research (CERQual) tool to the review find-
ings. The CERQual approach provides a transparent method of
assessing the confidence of findings of systematic reviews of qualita-
tive research.533 | RESULTS
3.1 | Search results
The search returned 2361 citations. About 1638 citations remained to
be screened after duplicates were removed. About 1558 citationsFIGURE 1 Preferred Reporting Items for Systematic Reviews and Meta‐
the abstract screening stages are available in Supplementary File 5 (foundwere removed from abstract screening (File S5) leaving 75 full texts
to be assessed for eligibility. Following full‐text review, 10 eligible
studies were included (see Figure 1 and File S1). The final repeat
search resulted in the inclusion of 1 additional full text. Therefore,
we included 11 studies, which described 9 study cohorts.3.2 | Characteristics of included studies
Of the 11 included studies, 4 were qualitative, 6 were quantitative,
and 1 was mixed methods. The characteristics of the included studies
are shown in Table 3. In total, the views of 526 GPs from 5 different
countries were represented.3.3 | Quality appraisal
We judged the overall quality of the qualitative studies in the review
to be high (File S6 and Table 1). The most common weakness was poor
reflexivity: only one study46 was found to have fully addressed this
issue. Three of the descriptive cross‐sectional studies were rated as
low quality (achieving only 3 out of 7 quality markers). These studies
all reported on the same cohort.54-56 The overall quality of the otherAnalyses (PRISMA) diagram. †Reasons for the exclusion of records at
in the Supporting Information)
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JENNINGS ET AL. 11694 descriptive cross‐sectional studies ranged from moderate to high
(File S6 and Table 2). Common areas of weakness were the lack of
involvement of the target population in the instrument develop-
ment45,54-56 and the lack of clarity on whether the sample used in
the study was likely to be representative of the study popula-
tion.45,54-56 None of the descriptive cross‐sectional studies provided
a sample size justification, statistical power description, or variance
and effect estimates.3.4 | Translation of included studies
The analysis led to the identification of 3 key concepts, which
encompassed 8 sub‐themes reflecting GPs' experiences of managing
BPSD. Each sub‐theme was supported by data from both qualitative
and quantitative studies. The findings supporting first‐order interpre-
tations are indicated by italicised quotations and those supporting sec-
ond‐order interpretations by non‐italicised quotations.4 | UNMET PRIMARY CARE NEEDSGPs' knowledge and self‐efficacy
Nearly all the included studies examined issues pertaining to GPs'
knowledge and self‐efficacy.12,44-46,55,57-59 In some studies, BPSD
was considered by GPs to be “very difficult to deal with”12 and
“distressing.”60 General practitioners tended to be “critical of their per-
ceived skills in the diagnosis and management of BPSD.”45 Specifically,
in some studies, GPswere critical of their knowledge of prescribing psy-
chotropic medications12,44: “When do you add in psychotropic medica-
tion, what type of medication, what dosages, for how long?”12 General
practitioners' perceived lack of knowledge impacted upon their confi-
dence prescribing these medications: “I do rely on psychiatry because I
admit that I am not the most knowledgeable person about people with agi-
tation and behavioral problems at home. I get a little nervous about anti‐
psychotic meds and I tend to send those people to psychiatry.”44 General
practitioners also lacked confidence when differentiating BPSD from
other potential causes of these behaviours and symptoms44,45:
“I want a second opinion too in making sure my diagnosis is correct.”44
In addition to GPs' lack of knowledge of and confidence in pharmacolog-
ical management in BPSD, GPs were also found to lack knowledge on
non‐pharmacological interventions46,55 and, at times, the confidence to
recommend them.45 However, in some of the studies, participating GPs
demonstrated a good knowledge of both non‐pharmacological and phar-
macological management options in BPSD.45,58,59 For example, in one
study, most GPs reported proactively reducing psychotropic medications
and routinely recommending non‐pharmacological interventions prior to
commencing medications59; however, these GPs still felt they required
“more training”59 in BPSD.Lack of defined pathways of care
Several studies identified the need for clearly defined pathways of care
that would allow GPs to access advice from relevant experts in the
area.12,44,45,58,60 The difficulty caused by long waiting lists was
highlighted44,45,60: “there's a weekly outreach clinic, but it can take severalmonths to get in.”60 Additionally, GPs identified difficulty accessing
other relevant health care professionals: “dementia care it's a team care,
dietician, social work, psychiatry, psychologist, and pharmacist…I feel I
don't have this.”44 General practitioners found identifying the relevant
members of the primary care team to be a “struggle.”12 In some studies,
there was “confusion regarding [the GP's] role”58 in BPSD. In many
studies, the GP emerged as an isolated figure when managing
BPSD,44,45,58,60 expressing “frustration [at] being placed in a situation
in which they felt compelled to provide care that they felt was beyond
their realm of expertise.”44 The need for “improved communication
and collaboration”58 between the different health care professionals
was highlighted to avoid GPs feeling that they are “left to deal with
the crisis on their own without back‐up.”45
Time‐intensive
The time required to assess and manage BPSD emerged as an issue in
several studies44,54,60: “… it's a lot more complicated than the intact 50‐
year‐old hypertensive diabetic.,”44 Addressing the needs of family care-
givers also required time44,54,60: “I spend as much time asking how the
caregiver's doing as I do the patient.”60 General practitioners sometimes
described feeling overwhelmed with the workload that a person with
dementia can generate: “I think we're all drowning … we are all truly try-
ing to keep our heads above water...These people do take a lot of time and
energy.”44 As a result of the time‐intensive nature of managing BPSD
and in the context of inadequate “reimbursement,”44 some GPs consid-
ered managing people with dementia to be burdensome: “they cause
chaos, and so they get referred or something happens.”44 The symptoms
and behaviours were “neglected”44 until an “emergency situation”54 or
“time of crisis.”445 | JUSTIFICATION OF ANTIPSYCHOTIC
PRESCRIBINGAntipsychotics to facilitate coping
In 4 studies,46,57-59 the prescribing of antipsychotics was seen to enable
carers, nursing home staff, and the person with dementia to cope with
BPSD: “he was weeping for his wife who has been dead for many years …
on quetiapine … the uncontrollable weeping had stopped.”46 Although in
some studies GPs were aware of the risks of antipsychotic prescribing
in people with dementia, these risks were seen to relate to longevity
of life whereas in BPSD “quality of life issues prevailed.”58 In several
studies, GPs' believed antipsychotics positively impacted on the quality
of life of people with BPSD.46,57,59 This contributed to their reluctance
to discontinue antipsychotics.46,57,59 Additionally, in 2 studies, GPs
expressed a concern that discontinuing the antipsychotic would lead
to a “return of challenging behaviours.”57,59
Barriers to implementation of non‐pharmacological
strategies
Several studies considered the challenges inherent to implementing
non‐pharmacological strategies in BPSD.45,54,57,58 A key finding in 3
of the studies that were conducted in nursing home settings related
to the influence of nursing home staff on the implementation of
1170 JENNINGS ET AL.non‐pharmacological strategies.57-59 Pressure from staff to prescribe
medication58,59 influenced the GPs' management decisions and acted
as a barrier to recommending non‐pharmacological strategies: “often
it is pressure from nursing homes … for medication to calm a patient down
that is trigger for prescribing.”58 One study found that in a nursing
home setting “nursing staff have the largest influence on prescribing
psychotropic medication.”59 However, this study also found that expe-
rienced GPs (in practice >20 years) were significantly less likely than
more recently qualified GPs “to rate pressure to prescribe from aged
care facility staff as a barrier”59 to recommending non‐pharmacologi-
cal strategies.
In a nursing home context, although a GP can recommend non‐
pharmacological strategies, their implementation typically falls to nurs-
ing home staff not to the GP. Two of the studies reported that chronic
understaffing of nursing homes57,59 acted as a barrier to the GP
recommending non‐pharmacological strategies. An additional factor
that hindered the implementation of non‐pharmacological strategies
in nursing home settings was the lack of shared perspectives57-59
between GPs and nursing home staff. For example, one study identi-
fied a “culture of blaming,” reporting that GP felt under pressure from
nursing home staff to prescribe, while nursing home staff reported
that it was the GPs that insisted on pharmacological treatment.58 A
final barrier to the implementation of non‐pharmacological strategies
was that in the context of “healthcare budgets and resource con-
straints,”58 guidelines on non‐pharmacological management strategies
were perceived to be impractical.45,58
Traditional prescribing role
In some studies,45,46,54,55 it was suggested that GPs were more com-
fortable with their role as prescribers of medications and less comfort-
able “with the more alien non‐pharmacological methods.”45 In several
earlier studies, GPs reported a preference for “medication as the pri-
mary intervention”54 and were found to be “wedded to a traditional
medical model of care.”55 In more recent studies,45,46 the value of
non‐pharmacological management strategies was increasingly
recognised. However, some participating GPs were still reluctant to
reduce their prescribing.46 Although accepting the important role of
non‐pharmacological management, “this belief was not put into clinical
practice”.45 A GP in one study felt that antipsychotics were sometimes
the “easy option, because it's something as doctors we do, we just pre-
scribe medications.”466 | PIVOTAL ROLE OF FAMILIESInfluence of family
The critical role played by family members in the management of
BPSD was highlighted by several studies that explored GPs' experi-
ences of managing BPSD in the community setting.12,44,54,60 General
practitioners' management of the person with BPSD was influenced
by the family45,54,60 who “contributed to making treatment processes
either more difficult or more straightforward.”60 The impact of pres-
sure from families was discussed in 3 studies.45,54,60 These studies
described “repeated phone calls” from family members54 or amismatch of expectations of the family and the capabilities of the
GP: “resistant children … who promised they'd never put mom in a nursing
home, but they don't want to take her … so we try to hire someone, which
is virtually impossible.”60 There was some evidence of GPs deflecting
responsibility for the management of BPSD back to the family:
“usually, the family deals with it [BPSD].”44 However, the important role
a GP plays in supporting carers was emphasised by GPs in several
studies12,44,60: “one of the big learnings I've had is … how important carer
support is.”12 Studies that focused on the management of BPSD in
nursing home settings found family members were less influential on
prescribing.59
Community‐based supports for family caregivers
General practitioners highlighted the importance of access to commu-
nity supports for family caregivers12,44,60: “I think you live on this lifeline
of getting this respite and that helps you to cope as a carer.”12 However,
accessing these supports was challenging for GPs. Supports some-
times were not there: “we don't have much in the way of support groups
... we are in a no man's land,”60or the GP did not know how to access
the supports: “I myself wouldn't be able to provide the specifics of it,”12
or the GP felt that providing information on these supports was
beyond their professional remit and capabilities: “since I'm not a
licensed clinical social worker and I don't know what's available in the
community …”446.2 | Impact of context on findings
Some studies focused on a subset of a GP's professional responsibility
for people with dementia. Three of the studies focused on GPs who
cared for people with dementia in a nursing home setting and
excluded those managing dementia in the community.46,57,59 Four of
the studies in the review focused on a singular aspect of the
management of BPSD, antipsychotic prescribing,46,57-59 and were con-
ducted by pharmacists or pharmacologists.46,57,59 The authors of the
remaining 8 studies were from other disciplines including psychiatry,
nursing, and general practice. They adopted a more holistic approach
to discussing the assessment and management of BPSD. Of note, only
one study was authored by a GP.12 Five of the 11 studies included in
this review were from the United States44,54-56,60 from which the sub‐
theme on “time” emerged. This may be influenced by factors specific
to the health care system in the United States.
The studies spanned 22 years (1995 to 2017). Over this time,
there have been substantial changes to recommendations regarding
the management of BPSD. Earlier studies described how antipsy-
chotics “may be the best available option for physicians.”54 However,
as the evidence for the harmful effects of using antipsychotic medica-
tions in people with dementia emerged,26,29 there has been a distinct
shift. The use of antipsychotics became less acceptable: “antipsy-
chotics should not be prescribed to reduce stress in carers …”46 The
studies in this review highlight the journey the management of BPSD
has travelled over the past 2 decades—from “what is the right psycho-
tropic to use?” to “should we be using psychotropic medication?” to
“stop using psychotropic medication.” A parallel journey occurred for
non‐pharmacological management strategies, which received
increased emphasis.
JENNINGS ET AL. 11716.3 | Synthesis
Six third‐order interpretations were iteratively developed by synthe-
sising the first‐order and second‐order interpretations. The third‐order
interpretations and their associated CERQual confidence levels are
shown in Table 4 and further expanded in File S7. These third‐order
interpretations were synthesised into a “line of argument,” which is
detailed in Table 5 and is represented graphically in File S8.7 | DISCUSSION
This is the first review to systematically review and synthesise the lit-
erature on GPs' knowledge, attitudes, and experiences of managing
BPSD. A wide range of issues were identified including the knowledge
and resource needs of GPs, the reliance on antipsychotic medications,
and the influential role of the family. These are areas that could be
targeted to improve the management of this challenging aspect of
dementia care.7.1 | Comparison with previous research
In this review, GPs were found to have a low sense of self‐efficacy
when managing BPSD. A systematic review on the barriers to diagnos-
ing and managing dementia in general practice identified that GPs' lim-
ited knowledge about dementia can act as a barrier to the provision of
optimum care to people with dementia.8 A previous quantitative study
of GPs' knowledge of and attitude towards dementia found that theTABLE 4 Summary of CERQual assessment
Review Findings/Third‐Order Interpretation
Relevant
Papers
CE
As
Co
Ev
Unmet primary care needs
1. Managing BPSD was complex, resource intensive
and sometimes unrewarding for the GP.
44,60 Lo
2. GPs lacked confidence when managing BPSD and
wanted input from either secondary care or relevant
members of the primary care team. However, the lack
of clearly defined care pathways meant that GPs
experienced difficulty accessing advice.
12,44,45,58,60 Hi
Justification of antipsychotic prescribing
1. GPs were more comfortable prescribing medication
than advising on non‐pharmacological management
strategies.
45,46,54,55,58 Mo
2. GPs found that antipsychotics enabled the person
with dementia, the family caregiver, the nursing home
staff, and the GPs themselves to cope with BPSD.
46,57-59 Hi
3. GPs had a tendency to over‐estimate the benefits
of antipsychotic prescribing. Consequently, in the
context of the challenges of implementing non‐
pharmacological alternatives, the risks associated with
antipsychotics were tolerated.
57,59 Lo
Pivotal role of family
1. The family of the person with dementia plays a
crucial role in the management of BPSD. However, the
needs of the carer could be intensive and challenging
for the GP, particularly in the context of limited
community supports for family caregivers.
12,44,60 Mo
Abbreviations: BPSD, behavioural and psychological symptoms of dementia; Gvast majority of respondents lacked confidence in the management of
BPSD, prompting the authors to recommend that future educational
support should focus on BPSD.11 While educational interventions are
a reasonable and important focus,61 it is likely that GPs' low sense of
self‐efficacy stems from more than a lack of knowledge of BPSD. Gen-
eral practitioners can find managing dementia stressful.62 The
resource‐intensive nature of managing BPSD coupled with the lack of
clearly defined pathways of care will impact on a GPs sense of self‐effi-
cacy when managing such a complex clinical condition. Previous sys-
tematic reviews have identified that to effectively change GPs'
behaviour in dementia care education alone is not sufficient; education
needs to be combined with service innovation ideally in the form of
organisational incentives.63,64 Although an increase in knowledge
would go some way towards improving GPs' self‐efficacy, GPs also
need to be supported by clear pathways of care and appropriate
resourcing.
Antipsychotics were considered to be justifiable in the context of
need. They were perceived to improve the quality of life of people
with BPSD and enabled everyone, including the GP, to cope with
the constraints imposed by insufficient resources. A recent systematic
review examined the influences on decision‐making on antipsychotic
prescribing in nursing home residents and found that that to circum-
vent the problems of inadequate resourcing antipsychotics were
“used” as cheap, fast, and effective staff members.65 In this current
review, the benefits of antipsychotics were often over‐estimated and
their potential harmful side‐effects were sometimes overlooked
because these side effects were perceived to relate to longevity of lifeRQual
sessment of
nfidence in the
idence Explanation of CERQual Assessment
w confidence Substantial concerns regarding adequacy and
minor concerns regarding methodological
limitations and relevance.
gh confidence Minor concerns regarding methodological
limitations and adequacy.
derate confidence Moderate concerns regarding the adequacy of the
data and methodological limitations. Minor
concerns about the relevance of the studies.
gh confidence Minor concerns regarding methodological
limitations, relevance and adequacy.
w confidence Substantial concerns regarding adequacy and
minor concerns regarding methodological
limitations, relevance, and coherence.
derate confidence Minor concerns about methodological limitations
and relevance. Moderate concerns regarding
data adequacy
Ps, general practitioners.
TABLE 5 Line of argument synthesis
Line of argument synthesis: GPs experience difficulties accessing supports for family caregivers and for themselves when managing BPSD. Under‐
resourcing, poorly defined roles, and a lack of integrated care pathways may contribute to GPs' feelings of isolation
and low self‐efficacy when managing BPSD. Low self‐efficacy is further exacerbated by the lack of practical,
implementable non‐pharmacological treatment strategies, which can lead to an over‐reliance on both family care‐
givers and psychotropic medications to fill the therapeutic void created. It appears that these conditions can
culminate in a reactive response to the care of people with BPSD where behaviours and symptoms may escalate
until an inevitable crisis point is reached.
Abbreviations: BPSD, behavioural and psychological symptoms of dementia; GPs, general practitioners.
1172 JENNINGS ET AL.rather than quality of life. Similarly, the systematic review on prescrib-
ing influences in nursing home residents found that inadequate knowl-
edge of the risks and benefits of antipsychotic prescribing in dementia
enabled inappropriate prescribing.65 However, the benefit of antipsy-
chotics in BPSD is minimal26 and many of the side effects, such as
extrapyramidal symptoms and sedation, occur in the short term. Gen-
eral practitioners' concern that discontinuation of antipsychotics will
lead to a re‐emergence of BPSD is also challenged by current evidence
that suggests that for most people with Alzheimer's type dementia,
antipsychotic discontinuation has no detrimental effect on cognition
or functional status.66
The care provided to the person with BPSD in the community
hinged on the positive involvement of family care‐givers. A recent
mixed‐methods systematic review of the challenges BPSD creates
for carers highlighted the importance of acknowledging the unmet
psychological needs of carers.67 The reliance on family caregivers, in
the context of inadequate community resources to support them, cre-
ates a burden of care that is likely to further impact on carers' unmet
psychological needs. Discussions on non‐pharmacological strategies to
manage BPSD often focus on a nursing home setting. However, BPSD
is not limited to nursing home settings. Recent research has found that
family carers observed significant levels of agitated behaviour, behav-
iour that they felt unprepared for as they were unaware that agitation
could occur as part of dementia.68 Carers value a proactive approach
to dementia care from GPs.69 Therefore, a more proactive initial dis-
cussion with family care‐givers on BPSD, combined with regular
screening questions as part of dementia reviews in general practice,
could help to address how unprepared carers feel when faced with
managing BPSD at home.7.2 | Implications
Our review highlights the complexity of managing BPSD and how, in
the face of this complexity, the care provided to people with dementia
is often reactive. This raises the question; what does proactive care
look like and how can this be delivered by GPs? Particularly in the con-
text of the challenges posed by resource limitations, low self‐efficacy
and uncertainty regarding roles and responsibilities. We acknowledge
that in clinical practice, pro‐active management of BPSD can be com-
plicated. Firstly, a prerequisite of any open, honest discussion on
BPSD is that the person's dementia has been diagnosed and fully
disclosed. However, we know that the diagnostic rates of dementia,
although improving,70 are low.71 Furthermore, although the majority
of people with dementia wish to know the diagnosis,72 GPs can bereluctant to fully disclose it.12,73,74 Secondly, GPs may be reluctant
to initiate a conversation about BPSD unless they feel comfortable
giving practical advice to family caregivers on managing BPSD, some-
thing many GPs struggle with.12,75,76 A final barrier to a successful
pro‐active conversation on BPSD can be an understandable unwilling-
ness on the part of family‐members, and sometimes the person with
dementia, to confront the unpleasant realities of cognitive decline.
This review identifies a number of potential targets for interven-
tions to improve the management of BPSD in general practice. There
is a clear need for interventions that address GPs' reliance on psycho-
tropic medications to manage BPSD and GPs' reluctance to discon-
tinue these medications. Other relevant areas to address include the
lack of resources in the nursing home setting, the lack of clarity
regarding roles, and responsibilities of different health care profes-
sionals and the limited availability of community‐based supports for
family caregivers. The challenge is how to implement effective inter-
ventions in the context of resource limitations, pressure to prescribe
medications, and a lack of clearly defined care pathways that interface
appropriately with secondary care and allied health care professionals
in the community. Existing interventions aimed at improving the man-
agement of dementia care in general practice have focused on educa-
tional initiatives.61,63,64,77 However, we know that educational
interventions alone have limited effect when attempting to change
GP practice in dementia care.63,64 To improve dementia care educa-
tional interventions in general practice should be combined with ser-
vice innovations such as dementia case managers64 and supported
by resources like decision support software.78
From the findings of this review, inappropriate antipsychotic pre-
scribing appears to be a relevant and worthwhile behaviour to target.
However, in addition to any educational component, an intervention
aimed at improving appropriate prescribing of antipsychotics in
dementia needs to be supported by practical resources that enable
GPs to implement best practice recommendations. A recent
randomised controlled trial demonstrated the potential for biannual,
structured, multi‐disciplinary medication reviews to improve appropri-
ate prescribing of psychotropic medications in nursing home patients
with dementia.79 Although psychotropic medication reviews may
occur in nursing homes, if implemented they are often performed in
an ad‐hoc manner without adequate resources and usually without
multi‐disciplinary input.
Medication reviews can reduce inappropriate antipsychotic pre-
scribing in dementia.80 However, to effectively improve the quality
of life of a person with dementia, strategies that aim to reduce anti-
psychotic prescribing, such as medication reviews, need to be com-
bined with evidence‐based non‐pharmacological interventions.81 A
JENNINGS ET AL. 1173systematic review of the effectiveness of interventions to reduce
inappropriate prescribing of antipsychotic medications in people with
dementia living in residential care settings identified that for long‐term
reduction in antipsychotic prescribing, interventions needed to
address cultural issues and the poor availability of non‐drug alterna-
tives to antipsychotics.82 It is clear that if an intervention is to achieve
a long‐term reduction in psychotropic prescribing in dementia, it must
provide options for practical, implementable, non‐resource intensive
approaches to non‐pharmacological strategies.7.3 | Strengths and Limitations
One of the strengths of this review is the rigorous approach used.
Each stage of the review process involved at least 2 authors working
independently. The synthesis of qualitative and quantitative studies
has led to a more substantive interpretation of the research phenom-
enon than is available from a single study; adding to, rather than
totalising, the available literature. Syntheses of qualitative data have
been criticised as being mechanistic. Indeed, there is the risk with
meta‐ethnography that the richness or integrity of the original work
will be lost,83 a concern that, by overly deconstructing the original
qualitative work, the researcher attempts to “sum up a poem.”84
Efforts were made to retain the content and context of the original
studies throughout the data extraction and analysis. Three members
of the review team are practising GPs (A. J., T. F., and C. B.); however,
the multidisciplinary nature of the review team, which included a phar-
macist (K. W.), a public health researcher (J. B.), and a nurse (AC),
helped to reduce the potential for professional biases.
The review did not include a search of the grey literature. Since
our search of the electronic databases was extensive, we felt that
the grey literature was unlikely to result in any additional insights. A
number of the studies included in the review focused on a singular
aspect of BPSD management: antipsychotic prescribing in a nursing
home setting. Hence, issues relating to antipsychotics may be over‐
represented in this review. Although integrated reviews of qualitative
and quantitative research is still a relatively novel approach, it has
been used effectively in previous mixed method systematic reviews
of similar research questions.48,67 It has enabled the integration of
the quantitative assessments of GPs' knowledge of and attitudes
towards BPSD with a more qualitative understanding of GPs' experi-
ences of BPSD, enhancing the review's utility and impact.
The focus of this review is on GPs who manage people with
dementia living at home and who may also provide care to people with
dementia in nursing homes. Other models of care, such as that in The
Netherlands where specially trained elderly care physicians provide
care to nursing home residents,43 were excluded from this review.
However, it was reassuring to find that many of the findings from
studies conducted with physicians working in the Dutch model of
nursing home care concurred with our review findings.85-87
To our knowledge, this is the first time the CERQual tool has been
used to assess the confidence of findings of a mixed‐methods system-
atic review of this kind. However, there are limitations to applying the
CERQual tool in this instance. In particular, the inherent “thinness” of
the data from the quantitative studies raised concerns when judging
the adequacy of the data. Nonetheless, the novel application of theCERQual tool to our review findings does provide a useful indication
of the confidence we have in the study findings.8 | CONCLUSION
This review offers new insights into GPs' perspectives on the manage-
ment of BPSD and highlights the limited research in this area. Most of
the research on dementia care in general practice appears to have
focused on diagnosis rather than the long‐term management of the
person with dementia. We need to explore the challenges of managing
BPSD in general practice, not at the expense of research on diagnostic
challenges, but at least with the same degree of depth. Targeted inter-
ventions that are supported by appropriate resourcing could make the
provision of high‐quality, personalised care to people with BPSD
achievable in a primary care setting. This review will help to inform
the design and development of interventions to support GPs manag-
ing BPSD, which should ultimately improve the quality of care deliv-
ered to people living with dementia.
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